TAT-RasGAP317-326, a cell-permeable peptide derived from the p120 GTPase-activating protein (RasGAP), bears anti-malignant activities, including inhibition of metastatic progression and tumor cell sensitization to cell death induced by anti-cancer therapies [7–12]. This evidence concerns the gene RASA1 and neoplasm.